Medical Cannabis Market To Reach $24.52 Million during 2020–2030


 

Increasing adoption of medical cannabis for cancer patient pain management and by those experiencing muscle spasms are factors driving market revenue growth.

Medical cannabis is deemed safer and has fewer side-effect as compared to other treatment options. It is used to treat nausea and combat negative side-effects, especially among patients undergoing chemotherapy, making the whole procedure more tolerable. The product is used with other opioid painkillers, which permits patients to reduce the dosage and frequency of opioids, relieving pain. Legalization of marijuana throughout the country could create up to 1 million jobs by 2025 in the U.S.

 

 Workers are needed to farm, process, distribute and sell marijuana and its related products. Medical cannabis has not only created jobs but have also generated significant amount of taxes. For instance, Colorado, in 2019, collected more than USD 302 million in taxes and fees on medical and recreational marijuana.

 

 

To get a sample copy of the Global Medical Cannabis Market report, visit @ https://www.emergenresearch.com/request-sample/174

The global Global Medical Cannabis market is highly consolidated due to the presence of a large number of companies across this industry. These companies are known to make hefty investments in research and development projects. Also, they control a considerable portion of the overall market share, thus limiting the entry of new players into the sector.  The global Global Medical Cannabis market report studies the prudent tactics undertaken by the leading market players, such as partnerships and collaborations, mergers & acquisitions, new product launches, and joint ventures.

Key players in the market include Canopy Growth Corporation, Aphria, Inc., Aurora Cannabis, Maricann Group, Inc., Tilray, Cronos Group, Organigram Holdings, Inc., Vivo Cannabis, Tikun Olam, and Insys Therapeutics, Inc.

 

Emergen Research has segmented the global Medical Cannabis market on the basis of product type, application, and route of administration, distribution channel, and region:

Product Type Outlook (Revenue, USD Billion; 2018-2028)

·         Oil

·         Buds

·         Tinctures

Application Outlook (Revenue, USD Billion; 2018-2028)

·         Chronic Pain

·         Mental Disorders

·         Anorexia

·         Seizures

·         Muscle Spasm

·         Cancer

·         Others

Route of Administration Outlook (Revenue, USD Billion; 2018-2028)

·         Oral

·         Intravenous

·         Inhalation

·         Topical

Distribution Channel Outlook (Revenue, USD Billion; 2018-2028)

·         Dispensaries

·         Online

 

Regional Outlook (Revenue, USD Billion; 2018–2028)

·         North America

1.      U.S.

2.      Canada

3.      Mexico

·         Europe

1.      Germany

2.      U.K.

3.      France

4.      Spain

5.      BENELUX

6.      Rest of Europe

·         Asia Pacific

1.      China

2.      India

3.      Japan

4.      South Korea

5.      Rest of APAC

·         Latin America

1.      Brazil

2.      Rest of LATAM

·         Middle East & Africa

1.      Saudi Arabia

2.      UAE

3.      Israel

4.      Rest Of MEA

To learn more details about the Global Medical Cannabis Market report, visit @ https://www.emergenresearch.com/industry-report/medical-cannabis-market

 

Key point summary of the report:

·         In October 2020, MediPharm Labs Corp. signed an exclusive supply agreement with STADA to meet the growing demand for medical cannabis in Germany. STADA wanted to be the go-to partner for generics, which is achieved by the partnership.

·         Chronic pain segment accounted for a significant revenue share in 2020. Medical cannabis is used to control pain of people suffering from multiple sclerosis and nerve pain. Patients claim that using medical cannabis allows them to resume their activity without feeling disengaged. Medical cannabis is used as a muscle relaxant, and it is common among people suffering from Parkinson’s. It also finds application in weight loss, nausea, and glaucoma. Doctors use it on patients suffering from PTSD, especially among veterans returning from combat zones.

 

To get a discount on the Medical Cannabis Market Market report, visit @ https://www.emergenresearch.com/request-discount/174

Thank you for reading our report. If you have any requests for customization of the latest report, kindly get in touch with us. Our team will assist you and ensure the report is designed as per your requirements.

Comments

Post a Comment

Popular posts from this blog

Global Jet Lag Therapy Market supplements market size to surge past USD 548.5 billion by 2027

Image
  The growth of the market is attributed to the increase in the number of travelers traveling to different time zones and new product launches associated with insomnia            Jet Lag Therapy Market has a wide range of advancements throughout the development of recent trend setting technologies that possess properties that prevent symptoms with less effects, as compared to traditional product such as prescription drugs and melatonin. Currently, attributing to the consistent R&D activities in conjunction with positive outcomes of clinical trials, the major market players operating in the market are fortunate in developing advanced and price effective tiredness management product like light-weight box, wearable mask, glasses, and ear buds among others.                                                             The report on the Keyword market gives an in-depth statistical analysis to examine the fastest growing sectors in the market while speculating the demand and supply,
Read more

Global Medical Cannabis Market Worth $24.52 Billion by 2028 - Exclusive Report by Emergen Research ®

Image
  Increasing adoption of medical cannabis for cancer patient pain management and by those experiencing muscle spasms are factors driving market revenue growth . The global  medical cannabis market  size is expected to reach USD 24.52 Billion at a steady revenue CAGR of 11.5% in 2028, according to latest analysis by Emergen Research. Increase in medical cannabis products and the rise in research activities are driving the market revenue growth. Moreover, legalization of the product in several countries is also propelling growth of the market.   The report, published by Emergen research, is a detail-oriented compilation of the crucial aspects of the Global Medical Cannabis market, including the key players’ product offerings, the wide application range of these products, the major market segments, leading market contenders, their company profiles, pricing strategies, production capacities, revenue generation schemes, technological advancements, and many others.   To get a samp
Read more

Advanced Metering Infrastructure Market To Reach $24.52 Million during 2019–2027

Image
  The increasing demand for the smart city and smart grid, and the growing need for energy across the world are driving the demand for the market. Market Size – USD 8.35 billion in 2019, Market Growth - CAGR of 15.4%, Market Trends –   The rise in IoT integration for real-time data about power consumption. The global Advanced Metering Infrastructure Market is forecasted to be worth USD 24.68 Billion by 2027, according to a new report by Emergen Research. The growing industrialization, urbanization, and population growth are expected to drive the advanced meter infrastructure market growth during the forecast period. The rising demand for smart cities and smart grid projects is also anticipated to boost the market growth shortly. However, the lack of government spending on infrastructure installations and lack of inter-operability standards in different regions are expected to hinder the market growth during the forecast timeframe.   The latest research report by Emergen Researc
Read more